ENFN News and Press, Enfusion Inc. Class A

2024-07-01 05:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-15 23:43:21 ET Summary Enfusion targets to grow its top line at a faster pace by optimizing its customer mix. Positive operating leverage and an increase in operating efficiency will support higher EBITDA margins for Enfusion. I expect ENFN to achieve revenue growth ac...

2024-06-11 07:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion’s Chief Executive Officer, Oleg Movchan, and Chief Financial Officer, Brad Herring, and Chief Operating Officer, Neal Pawar, will pa...

2024-05-11 12:13:13 ET Enfusion, Inc. (ENFN) Q1 2024 Earnings Conference Call May 9, 2024, 8:30 AM ET Company Participants Bill Wright - Head, Investor Relations Oleg Movchan - Chief Executive Officer Brad Herring - Chief Financial Officer Neal Pawar - Chief ...

2024-05-09 11:54:18 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Enfusion (NYSE: ENFN ) just reported results for the first quarter of 2024. Enfusion reported earnings per share of 6 cents. This was above the analyst estimate for EPS of...

2024-05-09 08:53:24 ET More on Enfusion Enfusion: TAM Penetration Continues To Progress Well Enfusion, Inc. (ENFN) Q4 2023 Earnings Call Transcript Enfusion stock retreats after Goldman downgrades to Sell Seeking Alpha’s Quant Rating on Enfusion ...

Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its first quarter 2024 financial results as part of its 1Q 2024 Shareholder Letter which can be viewed by navigating to the Financials section of its Investor...

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its first quarter 2024 financial results before the U.S. financial markets open on Thursday, May 9, 2024. Management will host a conferen...